Circassia Pharmaceuticals (GB:NIOX) has released an update.
Niox Group plc recently reported that Christopher Mills, associated with Non-Executive Director Nicholas Mills, acquired 8,064 shares of the company’s stock at £0.652 per share. This purchase raises Nicholas Mills’ total shareholding to 130,018 shares, representing 0.03% of Niox Group’s voting rights. The transaction was completed on the London Stock Exchange.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
